AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Dyspnea, Arterial Stiffness, and Cognitive Function in Adults with Elevated Cardiovascular Burden

By Watson J, Swatson E, Herring C et al.

Introduction: Adults with elevated cardiovascular disease (CVD) burden are at increased risk for cognitive dysfunction, with executive function and processing speed most sensitive to vascular pathology. Physical symptoms may reflect clinically meaningful cardiovascular vulnerability and identify individuals at greater risk for cognitive impairment. Arterial stiffness, endothelial activation, inflammation, and cellular aging pathways may contribute to symptom burden and cognitive dysfunction, but these relationships are not well characterized in adults with elevated CVD risk. Purpose: To examine whether symptom burden and arterial stiffness are associated with cognitive function and markers of vascular aging in adults with elevated CVD disease burden. Methods: Baseline data were analyzed from adults with elevated CVD burden enrolled in an ongoing study. Physical symptoms were assessed using the Heart Failure Somatic Perception Scale (HFSPS) and PROMIS Dyspnea Functional Limitations. Cognitive function was assessed using a battery summarized as standardized domain scores. Arterial stiffness was measured as pulse wave velocity (PWV). In an exploratory biomarker subset, circulating ICAM-1, VCAM-1, IL-6, TNFR1, MMP-9, and GDF-15 were measured using immunoassays. Composites were created for endothelial activation (ICAM-1, VCAM-1) and inflammation/remodeling (IL-6, TNFR1, MMP-9). Results: Participants (N=109) were 66±9 years of age, 63% female, and 43% Black and African American. PROMIS Dyspnea was associated with lower executive function (β=-0.176, p=.034), processing speed (β=-0.267, p=.001), and global cognition (β=-0.195, p=.017), adjusting for age, ethnicity, and sex. PWV was correlated with multiple cognitive measures in unadjusted analyses; after adjustment for age, ethnicity, and sex, PWV remained associated with worse executive set-shifting (β=0.250, p=.011). PWV was correlated with GDF-15 (r=.430, p=.018). Endothelial activation was associated with HFSPS total symptom burden (r=.395, p=.042). Inflammation/remodeling was associated with HFSPS total (r=.554, p=.003), dyspnea (r=.439, p=.022), and early/subtle symptoms (r=.401, p=.038). Discussion: Dyspnea-related functional limitation was consistently associated with poorer cognitive performance, particularly in executive function and processing speed, suggesting physical symptom burden may identify adults with elevated CVD burden who are also experiencing cognitive vulnerability. Arterial stiffness was independently associated with worse executive set-shifting, supporting a vascular aging contribution to cognitive cellular aging may reflect biologic pathways linking vascular aging and symptom burden. Clinically, dyspnea and other physical symptoms may provide accessible indicators of cognitive risk in adults with elevated CVD burden.

doi.org/10.1161/circ.154.suppl_1.8174Populations

AgingResearch.News